CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 63 enrolled
Drug / intervention
POD 26P AY FT +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04943809
NCT04943809N/ACompleted
CompareCT.gov

Comparison of Visual Outcomes After Implantation of the POD 26P AY FT (PhysIOL) and the POD 26P AY F (PhysIOL)

Beaver-Visitec International, Inc.·observational·Posted Jun 29, 2021·Updated Jul 1, 2021

In Brief

An observational study evaluating POD 26P AY FT and POD 26P AY F for Cataract. Completed, enrolled 63 participants across 1 site.

Detailed Summary

There is no difference of the photic phenomena in the two groups. The study will be a prospective non-randomised controlled study. The target is then to determine the equivalence in the glare. Assumption of Type I error is p=0.05 as level of significance and Type II error is alpha=0.8 as power.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 29, 2021
Enrollment StartJul 16, 2014
Primary CompletionJul 20, 2017
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.0 years ago

Interventions

POD 26P AY FTdevice

Routine cataract surgery

POD 26P AY Fdevice

Routine cataract surgery